A pilot study of Salix SST (saliva-stimulating lozenges) in post-irradiation xerostomia.
Relief from the effects of radiation-induced xerostomia resulting from use of saliva-stimulating lozenges (Salix) has been subjectively evaluated. Ten patients took Salix as required for 7 days; and self-assessed using analogue scales before and after treatment. There was a marked and statistically significant improvement in the dryness and general comfort of the mouth, and beneficial effects on eating, sleeping and speech.
Senahayake
F
F
Department of Radiotherapy, Royal Free Hampstead NHS Trust, London.
Piggott
K
K
Hamilton-Miller
J M
JM
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D005260:Female; D006258:Head and Neck Neoplasms / Q000532:radiotherapy; D006801:Humans; D008297:Male; D008875:Middle Aged; D004366:Nonprescription Drugs / Q000627:therapeutic use*; D008517:Phytotherapy; D010865:Pilot Projects; D010946:Plants, Medicinal / Q000627:therapeutic use*; D011878:Radiotherapy / Q000009:adverse effects*; D012472:Salivation / Q000187:drug effects*; D011795:Surveys and Questionnaires; D014987:Xerostomia / Q000188:drug therapy* / Q000209:etiology*
D004366:Nonprescription Drugs